Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Tilray Brands Expects to Hit a Major Milestone for the Current Fiscal Year: $1 Billion in Annual Revenue. Here's How it Plans to Get Therefool.com
The cannabis stock has struggled despite Tilray achieving solid growth in its most recent fiscal year.
Via The Motley Fool · August 10, 2026
3 TSX Stocks That Could Turn $30,000 Into $300,000https://www.fool.ca/2026/08/10/3-tsx-stocks-that-could-turn-30000-into-300000-3/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=b2b239fc-6c6d-43b8-a3cf-21b291ad2b3b
Turning $30,000 into $300,000 needs years of compounding and roughly a 10%–12% annual return, not a quick-stock miracle.
Via The Motley Fool · August 10, 2026
Prediction: Micron and Taiwan Semiconductor Manufacturing Stocks Will Both Rebound to Fresh Highs Before 2026 Endsfool.com
Micron and TSMC are at the core of the AI build-out.
Via The Motley Fool · August 10, 2026
Rigetti Computing Stock Surged -- Here Is What Is Driving the Rallyrigetti-com
While the long-term opportunity looks promising, the company still has a long road ahead before it becomes profitable.
Via The Motley Fool · August 10, 2026
Dole Q2 Earnings Call Highlightsmarketbeat.com
Dole (NYSE:DOLE) reported second-quarter revenue growth but lower profitability as elevated fuel, shipping and fruit-sourcing costs weighed on its Fresh Fruit segment. Management said consumer demand for fresh produce remained resilient, while Diversified Americas continued to provide an offset to p
Via MarketBeat · August 10, 2026
AbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trialmarketbeat.com
AbCellera Biologics (NASDAQ:ABCL) reported top-line four-week results from a Phase II trial of ABCL-635, an investigational non-hormonal treatment for moderate to severe vasomotor symptoms, or hot flashes, associated with menopause. The randomized, double-blind, placebo-controlled study enrolled 92
Via MarketBeat · August 10, 2026
Bitdeer Technologies Group Q2 Earnings Call Highlightsmarketbeat.com
Bitdeer Technologies Group (NASDAQ:BTDR) reported higher second-quarter revenue and a sharp improvement in adjusted EBITDA as growth in self-mining capacity and AI Cloud operations offset continued pressure on gross margins from depreciation and Bitcoin mining economics. The company also highlighte
Via MarketBeat · August 10, 2026
Niu Technologies Q2 Earnings Call Highlightsmarketbeat.com
Niu Technologies (NASDAQ:NIU) reported second-quarter 2026 revenue growth and higher unit sales, although the electric two-wheeler maker recorded a net loss as product mix changes, higher input costs and overseas inventory clearance weighed on margins. Total sales volume rose 24% year over year to
Via MarketBeat · August 10, 2026
Sohu.com Q2 Earnings Call Highlightssohucom
Sohu.com (NASDAQ:SOHU) reported second-quarter 2026 revenue of $136 million, up 7% from a year earlier but down 4% from the prior quarter, as marketing services and online game revenue both exceeded the company’s previous guidance. Chairman and Chief Executive Officer Charles Zhang said the company
Via MarketBeat · August 10, 2026
Axsome Therapeutics Q2 Earnings Call Highlightsmarketbeat.com
Axsome Therapeutics (NASDAQ:AXSM) reported second-quarter 2026 net product revenue of $218 million, up 46% from a year earlier, as sales of AUVELITY and SUNOSI increased and prescription demand for SYMBRAVO continued to build. The company posted a net loss of $51.3 million, or $0.99 per share, comp
Via MarketBeat · August 10, 2026
Elon Musk Says This Is One of the Biggest Challenges for Public Companiesfool.com
Both Tesla and SpaceX have achieved considerable growth in recent years, but their stocks carry significant risk and uncertainty.
Via The Motley Fool · August 10, 2026
Here's 1 Good Reason Not to Do a Roth Conversion Ahead of Retirementfool.com
It's a move that makes sense for a lot of people, but it may not be optimal for you.
Via The Motley Fool · August 10, 2026
eBay CEO Jamie Iannone Sells 22,220 Shares for $2.4 Million Amid a Surging Share Price. Here's a Deeper Look at the Transaction.fool.com
The e-commerce platform provider reported a notable insider sale as its share price increases 19% over the past 12 months.
Via The Motley Fool · August 10, 2026
3 Major Earnings Winners You May Have Missedmarketbeat.com
Vericel, Xenia Hotels & Resorts, and International Paper each posted Q2 2026 earnings with overlooked positives, from raised guidance to improved margins, despite mixed headline results.
Via MarketBeat · August 10, 2026
3 Energy Stocks With Dividends That Have Never Been Cutfool.com
Past performance is no guarantee of future results, but it certainly suggests what's likely.
Via The Motley Fool · August 10, 2026
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%investors.com
Vertex stock surged Monday after its competitor, Sionna, missed the mark for its highly anticipated cystic fibrosis treatment.
Via Investor's Business Daily · August 10, 2026
Lincoln Educational (NASDAQ:LINC) Exceeds Q2 CY2026 Expectations
Education company Lincoln Educational (NASDAQ:LINC) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 22.4% year on year ...
Via StockStory · August 10, 2026
How Much of the S&P 500's Return Actually Came From Dividends vs. Price Appreciation, by Decadefool.com
Dividends have become a smaller component of the S&P 500's total return, but that hasn't always been the case.
Via The Motley Fool · August 10, 2026
California Resources (NYSE:CRC) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops
Oil and gas producer California Resources (NYSE:CRC) announced better-than-expected revenue in Q2 CY2026, with sales up 58% year on year to $1.3 billion. Its...
Via StockStory · August 10, 2026
Ulcerative Colitis Market: Size, Trends, and Strategic Outlook 2026-2033talkmarkets.com
The Ulcerative Colitis market continues to advance as new therapies and diagnostics redefine patient management and commercial potential. Driven by increas
Via Talk Markets · August 10, 2026
Amazon Stock Hits a New All-Time High: Is It Still a Buy?fool.com
The tech giant got a huge boost from earnings recently.
Via The Motley Fool · August 10, 2026
Eli Lilly Upgraded, Best Buy Downgraded: Updated Rankings on Top Blue-Chip Stocksinvestorplace.com
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start.
Via InvestorPlace · August 10, 2026
AI Data Centers Are Splitting Winners From Pretenders in Infrastructure Stocksmarketbeat.com
AI data center demand is splitting the market: CoreWeave, Nebius and IREN show strong capital access, while Applied Digital and HIVE Digital face debt and dilution risks in the crypto-to-AI pivot.
Via MarketBeat · August 10, 2026
How to Reduce CNC Machine Vibration with the Right Anti Vibration Padstalkmarkets.com
CNC machines are designed for precision, speed, and repeatable performance. But even a well-maintained machine can develop vibration problems. Excessive vi
Via Talk Markets · August 10, 2026
Reliable Tree Service in Buffalo, NY – Woodcrest Tree Removal Delivers Safe, Affordable, and Professional Tree Caretalkmarkets.com
Trees add beauty, shade, and value to every property, but they also require regular care to remain healthy and safe. Overgrown branches, diseased trees, da
Via Talk Markets · August 10, 2026